Celltrion
068270.KS
#724
Rank
NZ$48.30 B
Marketcap
$235.70
Share price
0.05%
Change (1 day)
2.52%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$27.42 Billion

According to Celltrion 's latest financial reports the company's total assets are NZ$27.42 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31NZ$7.35 B5.42%
2021-12-31NZ$6.98 B9.02%
2020-12-31NZ$6.40 B29.22%
2019-12-31NZ$4.95 B5.93%
2018-12-31NZ$4.67 B7.53%
2017-12-31NZ$4.35 B25.97%
2016-12-31NZ$3.45 B5.2%
2015-12-31NZ$3.28 B21.32%
2014-12-31NZ$2.70 B18.5%
2013-12-31NZ$2.28 B12.54%
2012-12-31NZ$2.02 B30.47%
2011-12-31NZ$1.55 B17.04%
2010-12-31NZ$1.32 B98.67%
2009-12-31NZ$0.66 B-3.43%
2008-12-31NZ$0.69 B699.62%
2007-12-31NZ$86.61 M